trial · primary record
Adalimumab
REM Sleep Behavior Disorder
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 108 |
| Primary completion | 2030-01-01 |
| Primary endpoint | Change in Parkinson Disease Related Pattern (PDRP) expression |
| Registry ID | NCT06996652 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:14.725Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06996652
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Adalimumab · approval
- Adalimumab · compound